Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123102) titled 'Effect of Perioperative Dual Orexin Receptor Antagonist Use on Postoperative Delirium in Geriatric Surgical Patients' on April 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Rui'an City People's Hospital
Condition:
Postoperative Delirium
Intervention:
DORA Group:From 1 day before surgery to the 3rd day after surgery, for a continuous 4 days, take Relebresen 5mg 1 hour before bedtime each night.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-30
Target Sample Size: DORA Group:100;Placebo group:100;
Countries of Recruitment:
China
To know ...